← SynDRA
REV-5901
SynDRA canonical compound SYN0000276 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ALOX5 |
|---|
| Mechanism of action | Leukotriene receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Lipoxygenase inhibitor
- Leukotriene receptor antagonist
- ALOX5 INHIBITOR
Drug classes
- Anti-Inflammatory Agents, Non-Steroidal
- Antioxidants
- Lipoxygenase Inhibitors
- Platelet Aggregation Inhibitors
Cross-references
Synonyms
- REV-901
- Rev 5901
- RG 5901
- PF-5901
- alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol
- 1-[3-(quinolin-2-ylmethoxy)phenyl]hexan-1-ol
- CHEMBL8747
- MLS000069771
- SMR000058509
- alpha-Pentyl-3-[2-quinolinylmethoxy]benzyl alcohol
- Benzenemethanol, alpha-pentyl-3-(2-quinolinylmethoxy)-
- 1-(3-(quinolin-2-ylmethoxy)phenyl)hexan-1-ol
- SR-01000076105
- ACMC-20d0wb
- Opera_ID_512
- WNW5RYD8MG
- UNII-WNW5RYD8MG
- AC1L1JIU
- Lopac0_001042
- CBiol_001910
- KBioGR_000242
- BSPBio_001522
- KBioSS_000242
- MLS001076522
- PF 5901
- RefChem:555905
- JRLOEMCOOZSCQP-UHFFFAOYSA-N
- 2-[3-(1-hydroxyhexyl)phenoxymethyl]quinoline
- 1-{3-[(Quinolin-2-yl)methoxy]phenyl}hexan-1-ol
- SCHEMBL678489
- BML2-G04
- orb1704954
- SCHEMBL29369872
- CHEBI:91821
- KBio2_000242
- KBio2_002810
- KBio2_005378
- KBio3_000483
- KBio3_000484
Look up REV-5901 in the interactive SynDRA portal →